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Abstract 
Access to pharmaceutical services in rural areas has been affected by a national shortage of 
pharmacists. Telepharmacy, a subspecialty of telemedicine, has involved the utilization of 
telecommunications to deliver pharmaceutical services to consumers located at a distance. The number of 
telepharmacy programs in the United States and worldwide has been progressively increasing. The 
purpose of this research project was to examine the effect of the utilization of telepharmacy on rural 
hospitals’ access to pharmaceutical services. The methodology of this qualitative study was a literature 
review. Four electronic databases were employed to retrieve peer-reviewed journal articles, and three 
websites were accessed for pertinent information. Sixy-six articles were utilized as references. The 
findings demonstrate that telepharmacy networks have provided some benefits through which 
pharmaceutical access to rural areas has been enhanced. Networks have hastened medication order entry 
and order processing, increased on-call consultations and after-hours orders, and reconciled medications. 
Various states have reported promising results after implementing these networks. Moreover, networks 
have also permitted thorough checking of orders in both urban and rural pharmacies, thereby limiting 
medication errors. Overall, telepharmacy has had a positive effect on access to pharmaceutical services in 
rural areas. Such networks could diminish the problem of rural pharmacist understaffing, especially after 
hours and during vacations. Telepharmacy could also aid in reducing medication errors, which have 
increased as a result of the inability to recruit and retain pharmacists in rural areas. Telepharmacy should 
be utilized as a tool to maintain the pharmacist-consumer relationship. 
Keywords: access, hospital, medication error, regulations, rural, telepharmacy 
Introduction 
Technology plays a significant role in the lives of people all over the world and has improved access 
to medical care in rural areas.1 Telemedicine has been defined as medical or other health services given to 
a patient via a communication system, such as a computer, phone, or television, by a healthcare provider 
who is located at a significant distance from the patient.2 In many healthcare systems worldwide, telecare, 
which may include telemedicine, has become a means of providing healthcare that is centered on 
information and communication technology.3 A distinction between telehealth and telemedicine is 
warranted. The World Health Organization has classified telehealth as the use of computer-assisted 
telecommunications to support management, surveillance, and access to literature and medical 
knowledge, while telemedicine utilizes similar telecommunications solely to diagnose conditions and treat 
patients.4 
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As a subspecialty of telemedicine, the practice of telepharmacy has been defined by the National 
Association of Boards of Pharmacy as the provision of pharmacist care by registered pharmacies and 
pharmacists through the use of telecommunications to patients located at a distance.5 The worldwide 
scope of telepharmacy has been steadily rising; the scope of telepharmacy has been similarly intensifying 
in the United States, and many state pharmacy boards have enthusiastically instituted provisions for 
telepharmacy as a viable medium for pharmaceutical care.6  
Because this research study reviewed access to telepharmaceutical services in rural areas, it was 
imperative to distinguish between urban and rural areas. According to the US Census Bureau’s 
classification of urban and rural areas, urban areas represent densely developed territory and encompass 
residential, commercial, and other nonresidential urban land (areas with more than 50,000 people and 
clusters with 2,500 to 50,000 people), whereas rural areas encompass all housing, population, and 
territory not included within an urban area.7  
National pharmacist shortages have made it burdensome for hospitals located in rural areas to employ 
pharmacists.8 In addition, 924 independently owned rural pharmacies in the United States were lost from 
March 2003 to December 2013, with most of the closures occurring between 2007 and 2009.9 Therefore, 
telepharmacists have suggested that providing remote pharmaceutical care can help to resolve this 
situation.10 
The Food and Drug Administration has defined a medication error as any preventable event that may 
cause or lead to inappropriate medication use or patient harm while the medication is in the control of the 
healthcare professional, patient, or consumer.11 Each year, medication errors contribute to 250,000 
nonfatal injuries and 7,000 deaths.12 In rural areas, medications have been being provided without a 
pharmacist’s intervention because of the shortage of pharmaceutical services in hospitals, clinics, and 
medical centers in rural areas.13 A lesser response rate by small and rural hospitals has been observed in 
the American Society of Health-System Pharmacists (ASHP) survey of pharmacy practice in hospitals 
and the Institute for Safe Medication Practices hospital medication safety self-assessment surveys.14 It has 
been reported that small hospitals in rural areas have increased the number of part-time pharmacists. 
Critical-access hospitals have a median of only 20 on-site pharmacist hours per week, and 63 percent 
have an on-site pharmacist for less than 40 hours per week. A pharmacist shortage in Illinois has resulted 
in decreased time for providing clinical pharmacy services and a rise in pharmacy-related medication 
errors.15  
The purpose of this research project was to examine the effect of the utilization of telepharmacy on 
rural hospitals’ access to pharmaceutical services. 
Methodology 
The research framework for this review conformed with the steps and research framework used by 
Yao, Chu, and Li (2010).16 The framework elucidates the course of telepharmacy adoption to address the 
problem of limited access to pharmaceutical services in rural hospitals. To determine whether adoption of 
a telepharmacy network improves access to pharmaceutical services for hospitals in rural areas, an 
assessment of the effectiveness of telepharmacy networks must first be made. As seen with any project, 
the process of technology adoption follows a cyclic path. It begins when issues within the current system 
call for a review of needs, followed by formulation and implementation of a solution. The solution here is 
the adoption of a telepharmacy network. Prior to implementation of this solution, an evaluation of the 
benefits of and barriers to the adoption of a telepharmacy network is necessary. After its institution, needs 
are reassessed and the cycle continues. (See Figure 1.) Because the focus of this review is the process of 
application of new technology in healthcare settings, this research framework is suitable for the current 
study. Furthermore, the effective reproduction of this approach in previous studies supports its internal 
validity.17–20 
The primary hypothesis of this research project was that telepharmacy programs enhanced access to 
pharmaceutical services for hospitals in rural areas that do not offer 24-hour pharmaceutical services. The 
methodology for this study was an extensive and thorough literature review. The literature that was 
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utilized in this study encompassed primary and secondary sources. Because the term telepharmacy is 
relatively new and not widely known, peer-reviewed literature on this topic has been limited. Studies in 
the existing literature have typically described telepharmaceutical activities in a single hospital or a small 
number of hospitals in an area. 
Step 1: Literature Identification and Collection 
When executing the search, we employed the following keywords: “telepharmacy” AND “access” 
OR “hospital” OR “medication error” OR “regulations” OR “rural.” These keywords were the inclusion 
criteria for this study. PubMed, EBSCOhost, ProQuest, and Academic Search Premier were the electronic 
databases utilized to retrieve academic peer-reviewed literature. The literature was chosen after a review 
of the abstracts was conducted. Reputable websites of the Centers for Medicare and Medicaid Services, 
the U.S. Census Bureau, and the Food and Drug Administration were also studied for pertinent 
information. 
Step 2: Establishment of Inclusion Criteria and Literature Analysis 
The literature review included 66 references in which information relevant to the purpose of this 
study was scrutinized; these references met the inclusion criterion. Because of the technological and 
pharmaceutical orientation of the present study, the literature was based on a variety of key areas, which 
included the following: improved access to pharmaceutical services in rural areas in various states of the 
United States, varying state regulations and policies regarding telepharmacy networks, pharmacist 
shortages in rural areas, and the need for medication safety in rural areas. All the articles that were 
analyzed in this study were written in English. To obtain current research, references published from 2007 
to 2017 were included in this study. Four of the authors (B.M., C.S., H.S., and R.S.) conducted the 
literature search, which was validated by another author (A.C.), who acted as the second reader and 
double-checked to ensure that references met the inclusion criteria.  
Step 3: Literature Categorization 
The relevant articles were then categorized according to the research framework. The main categories 
that emerged from the literature were as follows: adoption and implementation (increased access and 
decreased time, regulations of telepharmacy), benefits (quality of care); and need for telepharmacy 
networks (shortage of pharmacists). These categories are detailed in the subsections of the Results 
section.  
Results 
Increased Access and Decreased Time  
Telepharmacy has been shown to enhance access to pharmaceutical services to hospitals in rural areas 
that do not offer 24-hour pharmaceutical services.21–24 A prospective cohort study was performed wherein 
a telepharmacy system was established between seven rural hospitals and a central hospital; the authors of 
the study concluded that the time required for medication order entry into the system drastically decreased 
(from 26.8 minutes to just 14 minutes per patient), since the rural pharmacies had to send patient 
information to just one central pharmacy, which stored all the information in its database.25 
A longitudinal study was conducted in three rural community hospitals in California, and it evaluated 
a newly installed telepharmacy system that linked these three hospitals with a central pharmacy.26 The 
results of the study indicated that after the network was established, the number of on-call consultations 
jumped from 15 to 98 within only the first month of utilization. Boon (2007) indicated that the time that 
rural pharmacists spent locating medications (with respect to the patient’s diagnosis) and processing 
orders was reduced to 60 minutes,27 while Witkowski (2007) revealed that instituting a telepharmacy 
network “decentralized” the pharmaceutical system and enhanced the turnaround time on patient order 
entries and checks on medications by 2 to 3 minutes.28 A pilot study demonstrated that a telepharmacy 
network assisted in resolving unreconciled medication orders that accounted for approximately 31 percent 
of total order entries and prospective order reviews; more importantly, the study suggested that a 
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telepharmacy network could reduce the turnaround time for the medication reconciliation process down to 
one hour.29 
Poulson, Nissen, and Coombes (2010) conducted a feasibility study in Queensland, Australia, to 
ascertain if a telepharmacy network (between one main hospital and two rural hospitals) was a viable 
medium through which access to rural inpatient facilities could be improved.30 The researchers indicated 
that improvements in the medication supply system and enhanced documentation of medications were 
achieved; moreover, underdosing of drugs (that had been prescribed for patients) was reduced from 7 
percent to 3 percent, patient counseling sessions increased from 2 percent to 4 percent, and erroneous 
patient medication histories were reduced from 26 percent to 22 percent.  
Regulations in Telepharmacy 
In the United States, state regulations and policies have been crucial in enhancing access to 
pharmaceutical services in rural populations; several states have implemented robust telepharmacy 
networks linking central pharmacies with rural pharmacies.31 North Dakota has been a pioneer state in 
establishing and implementing telepharmacy networks throughout various rural regions of the state since 
2001.32 In 2003, additional specific regulations were incorporated that focused on service agreements 
between central and rural pharmacies.33 Moreover, the North Dakota Board of Pharmacy has a provision 
for a licensure subclass for hospital telepharmacies.34 A study published in 2008 reported that after 
telepharmacy networks were established in the state, the networks reduced discrepancies in dispensing 
orders to less than 1 percent (as compared to the national average of 2 percent), since orders were checked 
and double-checked at both the rural and central pharmacies.35 
Two years later, another study scrutinized Montana’s telepharmacy system, which established its 
definition of telepharmacy in 2001 and in 2006 established specific regulations regarding the utilization of 
telepharmacy and remote medication-dispensing machine sites.36 This study also noted that for a remote 
telepharmacy site to obtain a practicing license, the site had to be located beyond a 10-mile radius from a 
central pharmacy and must undergo unscheduled visits from a central pharmacist. A cross-sectional pilot 
study indicated that after telepharmacy networks were established in Montana, the number of after-hours 
orders and subsequent follow-ups of these orders increased by 32.1 percent because telepharmacy 
networks could always provide an on-call pharmacist who did not have to be physically present at the 
rural hospital.37 
Shortage of Pharmacists 
The states of Utah, Oklahoma, Washington, Arkansas, and Minnesota have offered telepharmacy 
services only on a case-by-case basis; depending on the emergency of the situation, such as a severe 
pharmacist workflow shortage in a rural pharmacy, rural hospitals could electronically transmit 
medication orders to a central pharmacy, where orders were analyzed and reviewed.38 This study also 
revealed that after telepharmacy networks were implemented in Minnesota, more than 700 patient drug 
regimens were documented in the network via clinical messages within solely the first 20 months of 
network utilization.  
Studies in this arena have revealed that access to pharmaceutical services does not have to be limited 
to a single state.39 Pharmacists who are engaged in a telepharmacy network in a particular state have been 
licensed in that state, and some states have permitted the use of remote services of pharmacists from other 
states. For example, in North Dakota, pharmacists engaged in a telepharmacy network had to have a 
license within either the state or any contiguous state, and in South Dakota, pharmacists located in any 
adjacent state could provide services if the hospital facility in the state was a component of the 
telepharmacy network system in the adjacent state.40  
The importance of providing 24-hour pharmaceutical services has been supported by the fact that 
reductions in pharmacist personnel in rural areas have had a high correlation with medication errors, 
which include inaccurate dosages dispensed, increased unauthorized drug errors, and prescription errors; 
in other words, quality of care and medication safety have been adversely affected when unresolved 
pharmacist-related work issues were present.41 
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Quality of Care 
Some studies involving various scenarios (e.g., emergency departments) and procedures (e.g., 
chemotherapeutic drug preparations, patient medication regimens) have reported a reduction in 
medication errors with telepharmacy.42–50 (See Table 1.) In one study in which barcode technology was 
used with telepharmacy, medication error rates decreased from 1 percent to 0.2 percent.51 In another 
study, the implementation of a telepharmacy network increased to about 97.7 percent the use of barcode 
technology that improved accuracy in preparing chemotherapeutic drugs.52 A retrospective cross-sectional 
study from 2008 to 2010 showed an increase in quality management with the aid of a telepharmacy 
network, with the use of medication action, medication therapy review, and medication monitoring 
interventions accounting for 67 percent, 33 percent, and 4 percent, respectively.53 (See Table 1.) 
Discussion 
The purpose of this research project was to examine the effect of utilization of telepharmacy on rural 
hospitals’ access to pharmaceutical services. Results of the literature review demonstrated that 
telepharmacy networks have enhanced pharmaceutical access to hospitals in rural areas that do not offer 
24-hour pharmaceutical services.  
The literature review revealed several facts regarding the enhancement of access to pharmaceutical 
services in rural areas. Via telepharmacy, the time for entering medication order entries into the system 
decreased, the number of remote on-call consultations for rural inhabitants increased, and transit of 
patient order entries was made quicker. Moreover, the time spent locating medications within the system 
decreased (because the central pharmacy categorized medications by each rural patient), and errors in the 
consumer’s pharmaceutical history were curtailed. Telepharmacy has also substantially ameliorated the 
national predicament of pharmacist shortages since telepharmacy networks have linked central 
pharmacists with pharmaceutical technicians at rural pharmacies.54 A telepharmacy network could also 
improve stressful situations, such as evening, night, and weekend hours; it could also resolve problems in 
which pharmacists are unavailable during sick leave, vacations, or professional conferences as well as 
alleviate pharmacists’ workload.55 
Medication errors have many sources and contributing factors—of which a pharmacist shortage may 
be one. Reduction of medication errors has been a benefit of enhanced rural access to pharmaceutical 
services, and the literature review revealed several facts concerning these mistakes. Telepharmacy 
networks have substantially decreased the rate of such errors because multiple checks have to be 
performed at both the central pharmacy and the rural pharmacy; one report noted that the number of 
medication orders processed increased along with the accuracy of the processing system.56 Moreover, 
peripheral interventions, such as the establishment of drug regimen protocols, ultimately mitigate errors 
because these functions institute protocols that both central and rural pharmacists have to abide by. 
The utilization of telepharmacy has improved the quality of care by increasing medication accuracy 
and decreasing errors. The literature review revealed that medication safety has been enhanced by the 
tracking of error rates internally using barcode technology. The use of telepharmacy has improved the 
quality of care by monitoring other activities, such as accuracy of order entry, the number of after-hours 
orders, follow-up on after-hours orders, and productivity of pharmacy staff. 
Hospitals in rural areas have had to confront demographic and financial constraints that have made 
them vulnerable to medication errors.57 These areas have encountered difficulties in recruiting, attracting, 
and retaining pharmacists.58 More often than not, many rural pharmacies have been inclined to employ 
only a handful of pharmacists, because of financial cutbacks. As a result, the chance of medication errors 
has increased because worker shortages prevent pharmacists from double-checking orders.59 Moreover, 
rural hospitals have had to deal with an insufficiency of pharmaceutical innovations (that are available to 
their urban counterparts) necessary to boost pharmaceutical efficiency and prescription accuracy.60 These 
factors have resulted in medication errors, especially in rural settings. 
One of the most significant positive aspects of telepharmacy networks is that they require only 
software and videoconferencing capabilities to operate.61 This utility has made widespread utilization 
possible. Another benefit proposed by this analysis is that because remote pharmacists have been 
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involved in telepharmaceutical networks (in terms of double-checking prescriptions, confirming 
providers’ orders, and more), on-site pharmacists in rural areas could utilize the extra time to engage in 
concrete clinical services face-to-face with patients, thereby distributing the workload to enhance clinical 
care.62 In this way, this technology could permit rural regions to pool their limited resources to recruit and 
retain on-site pharmacists in these areas. Finally, these networks could contribute to the overall economic 
development in rural areas; the North Dakota Telepharmacy Project has brought about $12 million to the 
rural region where the network was implemented, as well as 80 to 100 additional jobs.63 
Telepharmacy has had a few negative aspects as well. On the basis of two studies conducted in the 
economic arena, we can extrapolate and surmise that telepharmacy networks in rural areas could hamper 
the business of traditional pharmacies located in adjacent cities because these companies would inevitably 
encounter reduced medication prescription volume.64, 65  
Opponents have also voiced concerns about the increased responsibility that inevitably falls on 
pharmaceutical technicians posted in rural areas, who represent the pharmacist in these areas; an 
underlying concern related to utilizing technicians has been that a variety of situations could require 
enhanced pharmaceutical expertise.66 Finally, it has been difficult to ascertain the entire scope of benefits 
that could be realized with telepharmacy because of the absence of a uniform telepharmaceutical system 
across the United States. 
Limitations of the literature review were due to restrictions in the literature search strategy because of 
the following reasons. Peer-reviewed literature on telepharmacy was limited because only four electronic 
databases were utilized. Additional databases were searched; however, these databases provided the same 
journal articles that were obtained from these four databases. Moreover, researcher and publication bias, 
which could have limited the availability and the quality of the research identified for this review, cannot 
be ruled out.  
A practical implication for the utilization of telepharmacy to enhance access to pharmaceutical 
services in rural areas ultimately involves the consumer’s interpretation of this technology. In the US 
healthcare system, it is imperative to maintain the foundational importance of pharmacist-consumer 
relationships; to this effect, telepharmacy should be utilized as merely a medium to facilitate and 
consolidate that relationship. However, there is an underlying fear that giant pharmaceutical chains could 
employ a large number of pharmacists in call centers to interact with rural consumers via 
videoconferencing. Such a scenario could certainly undermine the importance of the pharmacist’s role 
and provide the impression that pharmacy has evolved into a commercial business venture solely to boost 
sales and profit margins that could ultimately result in higher insurance premiums for consumers. Instead 
of viewing telepharmacists as caring healthcare specialists, consumers may become wary of 
telepharmacists and consider them agents of a pharmaceutical corporation.  
A tangential aspect of this practical implication is that if a rural consumer requires only a prescription 
refill and has prior comprehensive knowledge of the medication to be refilled, the consumer may believe 
that the pharmacist’s role is redundant and not as significant; as a result, the rural consumer might not feel 
the need for the services of a telepharmacist. In this case, a simple refill for a drug already prescribed 
might suffice. However, it is imperative for state boards of pharmacy to institute a policy that enforces 
some amount of interaction at least for those medications that consumers will ingest for the first time; in 
this manner, telepharmacy can aid in consolidating a relationship between the urban pharmacist and the 
rural consumer. 
Future research should examine the results attributable to the adoption of telepharmacy. A systematic 
review or a meta-analysis should be performed to obtain a more precise measurement of the effects (i.e., 
access and decreased time) of the implementation of telepharmacy in rural areas.  
Conclusion 
Telepharmacy may have significant potential to transform the delivery of pharmaceutical services. 
The literature review in this study has suggested that telepharmacy may enhance access to pharmaceutical 
services for hospitals in rural areas that do not offer 24-hour pharmaceutical services.  
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Selected Studies of Reduction in Medication Errors 
 
Authors (Year) Study Design Outcome 
Bubalo et al. (2013) Literature review Barcode technology coupled 




in only 1.1% of erroneous 
drug orders during one 
month.  
Kimber (2007) Direct observation-based 
methodology 
Barcode implementation 
within a network reduced 
medication error rates from 
1% to 0.2%. 
Erickson (2015) Literature review A network produced an 
increase to 97.7% utilization 
of the barcode technology 
that aided in maintaining 
accuracy in preparing 
chemotherapeutic drugs. 
Figge (2009) Literature review Utilization of the automated 
process within a network 
resulted in a 0.075% 
dispensing error rate. 
O’Neal et al. (2009) Direct observation-based 
methodology 
Telepharmacy and barcoding 
resulted in the need for 
pharmaceutical intervention 
for only 4 of 363 doses in 
order to confirm the accuracy 
of chemotherapeutic 
preparations. 
Cole et al. (2012) Retrospective chart review Before telepharmacy was 
incorporated into rural 
hospital pharmacy systems, 
the medication error rate was 
30%, compared to 19.2% 
after the incorporation. The 
total number of medications 
ordered after the 
incorporation (2,378) was 
more than four times the 
number (500) before 
incorporation. 
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With the aid of a 
telepharmacy network, the 
use of interventions 
significantly increased each 
year (36% in 2009, 55% in 
2010, and 7% in 2011) vs. 
3% in 2008 (baseline). Of the 
total number of remote 
pharmaceutical care 
interventions, medication 
action, medication therapy 
review, and medication 
monitoring constituted 67%, 
33%, and 4% respectively.  
Benizri et al. (2016) Quantitative and qualitative 
analysis 
A video system that utilized 
automatic verification 
procedures during critical 
stages of chemotherapy 
preparation was shown to 
identify 2.1% of preparation 
errors (244 of 11,640). 
Campbell et al. (2016) Retrospective chart review A network aided in clarifying 
12% (266 of 2219) of 
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